Gyre Therapeutics (GYRE) Current Taxes (2022 - 2025)
Historic Current Taxes for Gyre Therapeutics (GYRE) over the last 4 years, with Q3 2025 value amounting to $2.6 million.
- Gyre Therapeutics' Current Taxes fell 689.66% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 689.66%. This contributed to the annual value of $2.8 million for FY2024, which is 4398.5% down from last year.
- Latest data reveals that Gyre Therapeutics reported Current Taxes of $2.6 million as of Q3 2025, which was down 689.66% from $1.1 million recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Current Taxes registered a high of $6.5 million during Q1 2024, and its lowest value of $569000.0 during Q1 2025.
- Its 4-year average for Current Taxes is $2.9 million, with a median of $2.6 million in 2025.
- In the last 5 years, Gyre Therapeutics' Current Taxes skyrocketed by 14055.21% in 2023 and then crashed by 9120.56% in 2025.
- Over the past 4 years, Gyre Therapeutics' Current Taxes (Quarter) stood at $2.1 million in 2022, then soared by 140.55% to $5.1 million in 2023, then tumbled by 43.98% to $2.8 million in 2024, then fell by 6.53% to $2.6 million in 2025.
- Its Current Taxes was $2.6 million in Q3 2025, compared to $1.1 million in Q2 2025 and $569000.0 in Q1 2025.